Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003380095 | SCV004096190 | uncertain significance | Cardiovascular phenotype | 2023-08-24 | criteria provided, single submitter | clinical testing | The c.1457+5G>T intronic variant results from a G to T substitution 5 nucleotides after coding exon 16 in the MYBPC3 gene. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Clinical Genetics Laboratory, |
RCV004697288 | SCV005199336 | likely pathogenic | not provided | 2022-08-23 | criteria provided, single submitter | clinical testing |